Clinical Trials Browser

Phase 1 × INDUSTRY × terameprocol × Clear all

NCT00057512 2016-02-23

Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck

Phase 1 Completed

Head and Neck Neoplasms

NCT00664586 2016-02-23

A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors

Phase 1 Terminated

Lymphoma

NCT00664677 2016-02-23

Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Phase 1 Terminated

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00259818 2008-01-24

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors

Phase 1 Completed

Neoplasms